Renaissance Technologies (RenTech)'s RXRX Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 2.4 M shares of Recursion Pharmaceuticals, Inc. (RXRX) worth $7.37 M, representing 0.01% of the portfolio. First purchased in 2022-Q1, this short-term holding has been held for 8 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained this position in RXRX for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 2.4 M shares. Largest reduction occurred in Q3 2023, reducing 350,000 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Recursion Pharmaceuticals (RXRX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Recursion Pharmaceuticals (RXRX) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +2.4 M | New Buy | 2.4 M | $3.07 |
| Q3 2023 | -350,000 | Sold Out | 0 | $0.00 |
| Q2 2023 | -65,561 | Reduce 15.78% | 350,000 | $0.01 |
| Q1 2023 | +221,661 | Add 114.32% | 415,561 | $0.01 |
| Q4 2022 | +178,700 | Add 1175.66% | 193,900 | $0.01 |
| Q3 2022 | -246,400 | Reduce 94.19% | 15,200 | $10.66 |
| Q2 2022 | +83,200 | Add 46.64% | 261,600 | $8.14 |
| Q1 2022 | +178,400 | New Buy | 178,400 | $7.16 |
Renaissance Technologies (RenTech)'s Recursion Pharmaceuticals Investment FAQs
Renaissance Technologies (RenTech) first purchased Recursion Pharmaceuticals, Inc. (RXRX) in Q1 2022, acquiring 178,400 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Recursion Pharmaceuticals, Inc. (RXRX) for 8 quarters since Q1 2022.
Renaissance Technologies (RenTech)'s largest addition to Recursion Pharmaceuticals, Inc. (RXRX) was in Q1 2026, adding 2,400,605 shares worth $7.37 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 2,400,605 shares of Recursion Pharmaceuticals, Inc. (RXRX), valued at approximately $7.37 M.
As of the Q1 2026 filing, Recursion Pharmaceuticals, Inc. (RXRX) represents approximately 0.01% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Recursion Pharmaceuticals, Inc. (RXRX) was 2,400,605 shares, as reported at the end of Q1 2026.